TY  - JOUR
AU  - Muñoz-Garach, Araceli
AU  - Molina-Vega, María
AU  - Tinahones, Francisco J
PY  - 2016
DO  - 10.1007/s13300-016-0214-7
SN  - 1869-6953
UR  - http://hdl.handle.net/10668/10647
T2  - Diabetes therapy : research, treatment and education of diabetes and related disorders
AB  - Lack of control in diabetic patients has stimulated the development of new insulin analogues. One of these was basal insulin peglispro (BIL) or LY2605541; it had a large hydrodynamic size, flat pharmacokinetic profile, half life of 2-3 days and acted...
LA  - en
KW  - Basal insulin peglispro
KW  - Efficacy
KW  - Hypoglycemia
KW  - Pharmacodynamics
KW  - Pharmacokinetics
KW  - Type 2 diabetes
TI  - How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes.
TY  - research article
VL  - 8
ER  -